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ABSTRACT Conformational transitions are thought to be the prime mechanism of amyloid formation in prion diseases. The
prion proteins are known to exhibit polymorphic behavior that explains their ability of ‘‘conformation switching’’ facilitated by
structured ‘‘seeds’’ consisting of transformed proteins. Oligopeptides containing prion sequences showing the polymorphism
are not known even though amyloid formation is observed in these fragments. In this work, we have observed polymorphism in
a 15-residue peptide PrP (113–127) that is known to form amyloid ﬁbrils on aging. To see the polymorphic behavior of this
peptide in different solvent environments, circular dichroism (CD) spectroscopic studies on an aqueous solution of PrP (113–
127) in different triﬂuoroethanol (TFE) concentrations were carried out. The results show that PrP (113–127) have sheet
preference in lower TFE concentration whereas it has more helical conformation in higher TFE content ([40%). The structural
transitions involved in TFE solvent were studied using interval-scan CD and FT-IR studies. It is interesting to note that the a-
helical structure persists throughout the structural transition process involved in amyloid ﬁbril formation implicating the
involvement of both N- and C-terminal sequences. To unravel the role of the N-terminal region in the polymorphism of the PrP
(113–127), CD studies on another synthetic peptide, PrP (113–120) were carried out. PrP(113–120) exhibits random coil
conformation in 100% water and helical conformation in 100% TFE, indicating the importance of full-length sequence for b-
sheet formation. Besides, the inﬂuence of different chemico-physical conditions such as concentration, pH, ionic strength, and
membrane like environment on the secondary structure of the peptide PrP (113–127) has been investigated. At higher
concentration, PrP (113–127) shows features of sheet conformation even in 100% TFE suggesting aggregation. In the
presence of 5% solution of sodium dodecyl sulfate, PrP (113–127) takes high a-helical propensity. The environment-dependent
conformational polymorphism of PrP (113–127) and its marked tendency to form stable b-sheet structure at acidic pH could
account for its conformation switching behavior from a-helix to b-sheet. This work emphasizes the coordinative involvement of
N-terminal and C-terminal sequences in the self-assembly of PrP (113–127).
INTRODUCTION
Misfolded isoforms of the naturally occurring prion protein
(PrP) have been shown to be the causative agents in many
mammalian neurodegenerative disorders, including Creutz-
feldt-Jakob disease in humans, scrapie in sheep, and bovine
spongiform encephalopathy in cows (Prusiner, 1997). Prion
infectivity is unique in that the pathogenic prion form (PrPSc)
is involved in the conversion of the endogenous conforma-
tion (PrPc) into the transformed PrPSc. This leads to infusion
of transformed prion particles to ‘‘seed’’ the host for pro-
duction of large amounts of the pathogenic conformation
without the inﬂuence of foreign nucleic acids (Prusiner,
1982). The ‘‘protein-only’’ hypothesis (Harrison et al., 1997;
Prusiner, 1998) asserts further that no extraneous agents
are necessary to explain prion’s unusual behavior. This hy-
pothesis has been advanced by a number of in vitro exper-
iments involving recombinant and synthetic prion fragments
(Forloni et al., 1993).
The mechanism by which PrPc converts to PrPSc is still
unknown, although two major models have been proposed
(Kelly, 2000). The standard catalytic model (Huang et al.,
1996a) proposes that PrPc and PrPSc are distinct in
monomeric stable states, but the presence of PrPSc cata-
lyzes the conversion of PrPc to PrPSc. Alternatively, the nucle-
ated polymerization model (Lansbury and Caughey, 1995;
Caughey et al., 1995) suggests that PrPSc is intrinsically
multimeric, differing from PrPc primarily in its quaternary
structure. Changes in secondary and tertiary structure may
accompany this change in the polymerization state, as seems
to occur with amyloid formation (Kelly, 1998).
The uncertainty about the mechanism of the PrP structural
transition is due to the fact that the structure of PrPSc is yet to
be understood in atomic detail. The primary structure of PrPc
is composed of two structurally different parts: an extended
N-terminal segment (residues 23–125) with features of
a ﬂexible and disordered peptide chain and a well-deﬁned
globular domain (residues 126–231) with three a-helices and
two antiparallel b-sheets (James et al., 1997). The gross
structure of PrPSc is known to have more b-sheet content
(Forloni et al., 1996) than PrPc. A model for the tertiary
structure of PrPSc was also suggested (Huang et al., 1996b).
Recently, Wille et al. (2002) have proposed a parallel b-
helical structure for PrPSc based on their electron micro-
scopic work. This opens up a new experimental possibility of
prion’s assembly structure in the assembled form. However,
the dynamic details of structural transition need novel
methods to probe the solution state structure of prion peptide
fragments using spectroscopic techniques. Early conforma-
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tional studies have indicated that a transition from a-helical
to b-sheet structure (PrPc-PrPSc) is likely to be the crucial
event in prion propagation (Pan et al., 1993; Prusiner, 1998;
Prusiner et al., 1998; Petchanikow et al., 2001; Levy and
Becker, 2002). To investigate which amino acid sequences
feature in the conformational transition from PrPc to PrPSc
and PrP amyloid, several groups have analyzed the
secondary structure and ﬁbrillogenic properties of synthetic
peptides of PrP (Baldwin et al., 1995). Using these peptides,
it has been extensively studied and established that con-
secutive segment of prion protein spanning the residues
106–147 is important for the ﬁbrillogenic properties of the
protein (Tagliavini et al., 1991, 1993, 1994; Gioia et al.,
1994). In particular, the sequence comprising residues 106–
126 of human prion protein, which corresponds to a highly
conserved region of PrP, located in the N-terminal seg-
ment adjacent to the structurally organized globular domain
(Donne et al., 1997), is found to be neurotoxic (Forloni et al.,
1994). Moreover, it is also reported that in brain tissues of
patients of an Indiana family with Gerstmann-Stra¨ussler-
Scheinker disease, most of the ﬁbrillogenic sequence cor-
responds to residues 106–126 of human PrP (Tagliavini et al.,
1991, 1993).
PrP (106–126) consists of an N-terminal polar head
(KTNMKHM) followed by a long hydrophobic tail
(AGAAAAGAVVGGLG), and its structural characteriza-
tion is markedly inﬂuenced by several physiological factors
such as ionic-strength, pH, solvent composition, and other
factors (Gioia et al., 1994). This peptide readily forms amy-
loid ﬁbrils, which are resistant to proteinase K and pronase
digestion (Selvaggini et al., 1993); it is neurotoxic and in-
duces activation of astrocytes and microglial cells in vitro
(Brown, 1999). The conformational changes of PrP (106–
126) as a function of pH are conﬁned to both an alanine-
containing peptide sequence, AGAAAAGA (Ragg et al.,
1999) and a valine-rich tail part, VVGGLGG. Molecular
modeling studies (Huang et al., 1996b) have already
indicated that the pathogenical conversion of PrPc into
PrPSc might involve the AGAAAAGA region. Further,
AGAAAAGA peptide blocked the toxicity of PrP (106–
126), suggesting that this sequence is necessary for the
interaction of PrP (106–126) with neurons (Brown, 2000).
This indicates the possibility that the AGAAAAGA peptide
may show a therapeutic opportunity for controlling prion
disease. Gasset et al. (1992) have suggested that the hydro-
phobic part (VVGGLGG) may have no role in determining
the secondary structure of PrP (113–127).
We felt it is worthwhile to study the conformational
transition of AGAAAAGAVVGGLGG, an amyloid forming
fragment, and AGAAAAGA, a fragment known to form
nontoxic ﬁbrils and prevent amyloid propagation. To the best
of our knowledge, this is the ﬁrst time that this sequence is
subjected to detailed conformational analysis. The main
problem faced by the earlier workers was the solubility of
this sequence. Both the above peptides are virtually insoluble
in aqueous solution. We have preprocessed with an acet-
onitrile water mixture (1:1) with little formic acid to make
a solvated gel of the peptide. Interestingly this gel got dis-
solved dramatically in aqueous solutions and made this study
possible.
Conformational analysis of the above two peptides in
structure forming solvents such as 2,2,2-triﬂuoroethanaol
(TFE) was carried out. TFE has been used extensively to
enhance the helical propensity by various workers (Nelson
and Kallenbach, 1986; Jansanoff and Fersht, 1994; Bodkin
and Goodfellow, 1996; Luidens et al., 1996). In this work we
have investigatedwhether and howdifferent physicochemical
conditions such as pH and ionic strength or membrane-like
environment and concentration inﬂuence the conformation
and self-assembly of PrP (113–127).
MATERIALS AND METHODS
Peptide synthesis and puriﬁcation
The peptides PrP (113–127) and PrP (113–120) were synthesized by manual
solid phase chemistry, using t-butyloxy carbonyl group (Boc) as the
protective group for N-terminal ends, and 1-hydroxy benzotriazole (HOBt)
and N, N-dicyclohexyl-carbodiimide as activators of carboxylic ends. The
peptides were cleaved from (4-methyl benzhydrylamine) MBHA resin with
triﬂuoromethane sulfonic acid/thioanisole/ethanedithiol/triﬂuoroacetic acid
(1:1:1:7) (Stewart and Young, 1984) and precipitated with cold ether. The
composition of peptides was determined by amino acid analysis using the
phenyl isothiocyanate (PITC) method. The puriﬁed peptide was identiﬁed by
matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) analysis. All reagents used in peptide synthesis were of
the purest analytical grade; t-butyl carbazide, HOBt, N, N-dicyclohexyl-
carbazide, and triﬂuoroacetic acid were purchased from Aldrich (Seelze,
Germany). Boc-amino acids were prepared using standard procedures
(Katsoyannis and Schwartz, 1977; Bodanszky and Bodanszky, 1984) and
were characterized by thin-layer chromatography and FTIR spectroscopic
studies.
Predicted secondary structure
The a-helix and b-sheet propensities were calculated by the Chou and
Fasman secondary structure prediction algorithm (Chou and Fasman, 1978)
using the program Peptide Companion version 1.24.
Circular dichroism spectroscopy
To investigate the inﬂuence of the a-helix stabilizing solvent 1,1,1-
triﬂuoroethanol (TFE) on the secondary structure of the peptides, TFE
titrations were carried out. Similar stock solutions of the peptides in a
phosphate buffer (50 mM, pH 7) and in neat TFE were prepared. The two
stock solutions were mixed in such a way as to give different concentration
of TFE. CD spectra have been recorded at a temperature of 300 K and at 0%,
5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%,
and 100% TFE.
To analyze the effects of sodium dodecyl sulfate (SDS) micelles on the
PrP (113–127) and PrP (113–120) conformation, CD spectra were collected
from a solution of 5% SDS in deionised water. SDS was obtained from SRL
(Mumbai, India); TFE was purchased from Aldrich.
CD spectra were recorded in a quartz cell with an optical path of 0.1 cm
using a Jasco J-715 (Tokyo, Japan) spectropolarimeter at a scan speed of 50
nm/min. The percentages of the secondary structures of PrP (113–127) and
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PrP (113–120) were calculated using the SELCON3 program (Sreerama
et al., 2000).
FT-IR studies
The FT-IR spectra have been recorded in the Avatar 310 thermonicolet
spectrometer (32 scans, resolution: 1 cm1). The Fourier self-deconvoluted
IR spectra (FSD) have been obtained by using the Nicolet software with
a reduction factor of 2.5 and a bandwidth of 15 cm1. All the IR spectra were
recorded at 300 K.
TEM studies
Electron microscopy was carried out by using specimen grids that were
coated with 0.25% formvar and the carbon and subjected to glow discharge
(Prusiner et al., 1983). Five microliters of gel stock of PrP (113–127) was
applied to a grid for 1 min before any excess was washed away. Negative
staining was performed in uranyl acetate for 10 s (Williams, 1977; McKinley
et al., 1986). Specimen grids were examined by using PHILIPS electron
microscopy at 80 keV.
RESULTS AND DISCUSSION
The aim of this work is to analyze the intermediate
conformational preferences in the polymorphic behavior of
AGAAAAGAVVGGLGG. The individual domain confor-
mational preferences, the helix (A) or sheet propensity (B) of
each residue for the full sequence has been carried out by the
Chou and Fasman method and is depicted in Fig. 1. The
results indicate that the 113–127 sequence has two major
domains, a helical conformation favoring the 113–118 se-
quence and a b-sheet forming domain consisting of resi-
dues of 118–122, thereby indicating that this peptide has
the tendency to form both helical and sheet conformation.
Our results indicate that PrP (113–127) in 100% water
exhibits b-sheet conformation, whereas it takes a-helical
structure in 100% TFE. The smaller N-terminal segment PrP
(113–120), an alanine-rich sequence, exhibits random coiled
structure in 0% TFE and helical structure in 100% TFE. CD
spectra in the region of 260 to 185 nm for PrP (113–127) and
PrP (113–120) in different TFE concentrations in aqueous
solutions are shown in Fig. 2 and Fig. 3, respectively. The
increase in the TFE concentration from 0% to 80% of the PrP
(113–127) solution results in a shift of positive maximum
FIGURE 1 The amino acid sequence, a-helical and b-sheet probability
for PrP (113–127) and PrP (113–120). The single and double bar represent
the region of PrP peptides having a high probability of b-sheet and a-helical
structures, respectively.
FIGURE 2 CD spectrum of PrP (113–127) in phosphate buffer (0.05 M,
pH 7) titrated with neat TFE at 293 K. (a) a, 0; b, 5; c, 10; and d, 15% TFE
(v/v). (b) e, 20; f, 25; g, 30; h, 40; i, 50; and j, 60% TFE (v/v). (c) k, 70; l, 80;
m, 90; n, 95; and o, 100% TFE (v/v). Concentration of PrP (113–127) is 0.7
mM.
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from 199.3 to 190 nm, and the value of [u]222 shifts from
7621 to 10,660 deg cm2 dmol1 in the CD spectra. This
indicates the structural transition from sheet to helical
conformation. Around 15% TFE, the CD curves are char-
acteristic of b-sheet plus undeﬁned structure, as charac-
terized by the presence of an isodichroic point at 210 nm
(Fig. 2 a). Between 20% and 60% TFE, the spectrum under-
goes a major change and exhibits features suggestive of a-
helical structure (Fig. 2 b). The maximal helix formation is
found to occur at 80% TFE (Table 1) and on further increase
in concentration of TFE, the CD spectrum exhibited a sig-
niﬁcant decrease in the signal intensity (Fig. 2 c; Table 1).
The positive maximum is located at 190 nm, with the neg-
ative maximum at 205.7 nm and the value of [u]222 ¼
10,177 deg cm2 dmol1 (in 100% TFE). At low TFE
concentrations (\15% TFE), the intrinsic preference of
the peptide to form b-structure is manifested due to the
stabilization of intermolecular hydrogen bonding at this mi-
croenvironment. However, at higher TFE concentrations,
the hydrophobic interior of the b-sheet structure would be
disrupted and the PrP (113–127) then refolds as an a-helix.
Molecular interactions that stabilize helix formation in
peptides are dependent not only upon sequences but also on
the molecular environment (Merukta et al., 1990). It has
been shown for many peptides that the increase in TFE
concentration results in further increase in the degree of
helicity (Nelson and Kallenbach, 1986; Lehrman et al., 1990;
Bruch et al., 1991; Storrs et al., 1992) or helix formation
reaches a plateau (McLeish et al., 1994; Pintar et al., 1994;
Wilson et al., 1994; Zhang and Vogel, 1994; Xu et al., 1995).
In this study, for the PrP (113–127), helix formation in-
creases with increase in TFE concentration, and it reaches
a maximum at 80% TFE. However, further increase in TFE
concentration leads to a decrease in helicity of the PrP (113–
127), indicating destabilizing interactions that are reinforced
in a hydrophobic environment (Fig. 4 a; Table 1).
These results suggest that TFE stabilizes the helical
structure of PrP (113–127), which has the preference for b-
sheet conformation in water. TFE is known to be a denaturant
and destabilizes hydrophobic regions of the protein. Since
the b-sheet structure involves the alignment of noncontig-
uous regions of the polypeptide chain and is thought to be
stabilized by packing of nonpolar residues in the interior of
the sheet, it is proposed that TFE can denature such structure.
Our titration data, together with the data reported from other
groups (Nelson and Kallenbach, 1986; Lehrman et al., 1990;
Bruch et al., 1991; Storrs et al., 1992; Chakrabartty et al.,
1993; Zhou et al., 1993; McLeish et al., 1994; Pintar et al.,
1994; Wilson et al., 1994; Zhang and Vogel, 1994; Albert
and Hamilton, 1995; Xu et al., 1995), emphasizes the crucial
role of hydrophobic interaction in helix to sheet transition.
Further, the titration data for PrP (113–127) suggests a loss
of helicity above 80% TFE (in enhanced hydrophobic
environment), which is similar to that observed in poly-
alanine-based peptides by Chakrabartty et al. (1993).
The plot of % b-sheet conformation versus TFE con-
centration for PrP (113–127) is also shown in Fig. 4 a. It
is tacit that between 0% and 10% TFE, there is no notice-
FIGURE 3 CD spectrum of PrP (113–120) in phosphate buffer (0.05 M,
pH 7) titrated with neat TFE at 293 K (0! 100% TFE (v/v)). Concentration
of PrP (113–120) is 0.26 mM.
TABLE 1 Estimates of secondary structure in PrP (113–127)
from analysis of CD spectra
% of secondary structure for PrP (113–127)
a-helix b-sheet b-turn Random coil
a. %TFE
0 5.2 44.9 16.5 31.4
5 5.3 44.9 18.6 29.1
10 3.6 45.4 21.6 32.9
15 3.3 40.6 25.5 32.0
20 5.9 36.7 24.9 32.2
25 6.7 34.5 26.8 38.5
30 14.0 26.2 23.1 29.6
40 24.8 23.4 21.6 31.5
50 31.5 18.9 19.5 29.2
60 34.4 16.9 19.3 28.5
70 36.3 11.1 20.0 31.0
80 38.4 9.6 18.3 31.4
90 35.1 11.5 20.4 30.5
95 36.4 12.4 19.7 30.0
100 36.0 15.4 19.1 29.1
b. Concentration, mM
0.17 41.7 14.8 18.7 26.0
0.86 38.0 15.8 19.6 27.0
1.21 33.9 18.7 18.8 28.0
1.73 30.2 21.5 20.1 27.9
2.25 25.0 27.0 21.4 27.4
2.95 24.3 29.9 20.2 26.0
c. 5% SDS solution 44.7 13.6 16.4 26.6
d. pH
2 1.7 43.4 21.2 32.4
5 6.2 43.0 18.7 29.9
7 5.2 44.9 16.5 31.4
10.6 22.5 41.6 14.8 22.0
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able change in the sheet content. However, after TFE attains
15%, there is a rapid decrease in sheet preference and attain-
ment of the minimal value of sheet conformation at 80%
TFE. These observations suggest that the conformational
transition determined by the hydrophobic or hydrophilic
environment is a two-stage process. The loss of helicity is
compensated by gain of the sheet structure.
To probe the role of AGAAAAGA in determining the
conformation of PrP (113–127), a TFE titration study was
carried out on PrP (113–120) (Fig. 3). Unlike the 15-residue
sequence, the PrP (113–120) takes random coil conformation
in 100% water and helical conformation in 100% TFE (Table
2). In proteins or peptides, random coil conformation is
characterized by a negative absorption between 195 and 200
nm (Greenﬁeld and Fasman, 1969). Random coil conforma-
tion of PrP (113–120) in 0% TFE is deduced by the strong
negative absorption at 195 nm (Fig. 3). On increasing the
concentration of TFE, the proportion of random coiled
structure of PrP (113–120) decreases gradually with increase
in helical conformation. The structural transition of PrP (113–
120) from coil to helical structure on increasing the TFE
concentration is accompanied by shift of the negative
maximum (195 nm) of random coiled structure to p-p*
exciton component (204nm) of helical structure, and the value
of [u]222 increases from 409 to 9248 deg cm1 dmol1.
The increase of a-helicity is attributable to the increase in
hydrophobic stabilizing interaction (Zhou et al., 1993).
The CD spectroscopic data for PrP (113–120) in differ-
ent concentrations of TFE indicate the existence of two
conformations, random coil and a-helix. This inference is
further supported by the presence of an isodichroic point at
200.5 nm (Fig. 3), where the [u] intensities are equal. Also,
it could be seen from Fig. 4 b that the slope (m ¼ 0.27, R2
¼ 0.949) of decrease in % random coil structure with in-
creasing the TFE concentration is almost equal to the
slope (m ¼ 0.26, R2 ¼ 0.954) of increase in % helicity with
TFE concentration. The results could be explained by the
TFE property, which is known to stabilize the ‘‘nascent
helices’’ (Jansanoff and Fersht, 1994) even in small
fragments. Further the SELCON3 analysis reveals that there
is an increase in % helicity from 3.2 (0% TFE) to 28.5 (100%
TFE) and % unordered form decreases from 59.6 (0% TFE)
to 29.6 (100% TFE); the same is given in Table 2. In a fully
aqueous environment, the dominant interactions are inter-
molecular interactions, and in high TFE, the intramolecu-
lar interaction predominates (Myers et al., 1998). However,
for the peptide PrP (113–120), the lack of b-sheet structure
indicates that in aqueous solution such intermolecular as-
sociation is possible only with more hydrophobic sequences.
This is because the hydrophobic sequence will lead to ag-
gregation that will lead to intermolecular interaction.
FIGURE 4 (a) Plot of degree of helicity of PrP (113–127) (d) and degree of sheet structure (m) with TFE concentration. A decrease in helicity at high TFE
concentration indicating a destabilizing effect in a hydrophobic environment. (b) Plot of degree of helicity of PrP (113–120) (d) and degree of random coiled
structure (m) with TFE concentration. An increase in helicity with increase with TFE concentration, indicating stabilizing interactions that are reinforced in
a hydrophobic environment.
TABLE 2 Estimates of secondary structure in PrP (113–120)
from analysis of CD spectra
% of secondary structure for PrP (113–120)
a-helix b-sheet b-turn Random coil
a. % TFE
0 3.2 6.2 23.7 59.6
5 3.5 12.6 24.0 58.1
10 9.3 13.1 26.3 51.7
15 7.7 16.4 24.5 52.4
20 9.6 18.7 23.1 47.9
25 11.9 18.6 24.8 47.9
30 12.4 17.6 25.4 46.3
40 17.5 17.4 24.5 43.2
50 20.7 16.3 21.8 40.9
60 22.0 21.4 19.0 36.9
70 25.9 21.7 19.8 34.9
80 24.7 24.3 19.2 30.7
90 28.4 17.7 20.4 34.0
95 26.8 20.7 21.1 32.0
100 28.5 20.9 21.0 29.6
b. 5% SDS solution 24.3 13.0 16.1 42.9
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The importance of aggregation-promoted sheet formation
is explored by studying the conformation of PrP (113–127)
at different concentrations. The representative CD spectra of
PrP (113–127) at 0.17, 0.86, 1.21, and 2.95 mM, are shown
in Fig. 5. The amount of secondary structure calculated for
the different concentrations of PrP (113–127) in TFE are
tabulated in Table 1. It is found that at higher concentration,
sheet structure predominates even in TFE, indicating that at
these concentrations the molecular crowding effect operates,
leading to b-sheet formation.
To further assert the effect of molecular crowding on the
structure of PrP (113–127), an interval scan CD study with
TFE was carried out. A dilute solution of peptide (0.17 mM)
in TFE was sandwiched between two quartz plates, and the
solvent TFE was allowed to evaporate slowly. CD spectra
were recorded during the removal of TFE from the peptide
environment. The interval scan CD spectrum is shown in
Fig. 6 a. From the ﬁgure it could be noted that removal of
TFE molecules around the peptide backbone results in more
sheet conformation at the expense of helical and unordered
structures. This makes one infer that in absence of a solvent
(TFE) environment, PrP (113–127) takes predominantly
sheet conformation (Fig. 6 a). A similar study was also
performed using an interval scan FT-IR spectrometer, using
ZnSe diskettes. The FT-IR spectra taken at different time
intervals of time on removal of TFE from the peptide
backbone are shown in the inset of Fig. 6 a. In the presence
of TFE, PrP (113–127) shows a mixture of helical (1656
cm1), sheet (1627 cm1), and unordered (1647 cm1)
conformations, which is consistent with the CD studies,
whereas removal of solvent TFE from the peptide backbone
results in b-sheet (antiparallel) structure. A notable feature
observed was the persistence of a-helical content in the
structural transition, indicating the importance of helical turn
conformation in the aggregation process. There are reports in
favor of the view that most of the proteins may start their life
in an a-helical conformation, even if their later state is to
be b-sheet, indicating that the helix nucleation is more
kinetically stabilized when compared to b-sheet structure.
Moreover, the existing sheet structure of PrP (113–127) in
the xerogel state (inset of Fig. 6 a) exhibits two types of
carbonyls (1637 and 1627 cm1) in addition to helix (1656
cm1) and coil (1647cm1) structures. The conformational
transition is also accompanied by increase in absorbance
of peak at 1689 cm1, suggestive of antiparallel sheet
conformation.
The interval scan CD spectrum of PrP (113–120) on
gradual removal of TFE is shown in Fig. 6 b. It is inferred
from the ﬁgure that removal of TFE molecules around
the peptide backbone results in more sheet structure at the
expense of unordered structure. The interval scan FT-IR
FIGURE 5 CD spectrum of PrP (113–127) in a (——) 0.17 mM, b
(— —) 0.86 mM, c () 1.21 mM, and d () 2.95 mM in TFE.
FIGURE 6 (a) Interval scan CD and FT-IR spectra (inset) of PrP (113–127), on evolution of TFE. (b) Interval scan CD and FT-IR spectra (inset) of PrP
(113–120), on evolution of TFE.
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spectra of PrP (113–120) on TFE evolution are shown in the
inset of Fig. 6 b, which is in agreement with CD studies. This
makes one conclude that in the absence of a solvent (TFE)
environment, PrP (113–120) takes dominant sheet confor-
mation, which is indicated by the peak at 1627 cm1,
depicted in Fig. 6 b. In the CD spectrum, the negative band
near 219 nm is assigned to the n-p* transition, whereas the
positive band near 200 nm is assigned to the p-p* exciton
component (Madison and Schellman, 1972). Weakly twisted
sheets have n-p* and p-p* maxima of approximately equal
magnitude; and for strongly twisted sheets, the p-p* band at
200 nm is much stronger than the n-p* band (Fasman,
1996). From the xerogel CD spectra of both the peptides, it is
inferred that the p-p* exciton component of PrP (113–120)
(up-p*/un-p* ¼ 4.7) is stronger than that of PrP (113–127)
(up-p*/un-p* ¼ 2.7), suggesting PrP (113–120) sheet con-
formation is more twisted than PrP (113–127). The results
indicate that both the peptides take antiparallel b-sheet
conformations in the solid state, which are found to be in
agreement with ATR-FTIR studies of Gasset et al. (1992).
SDS is an amphipathic molecule extensively used to mi-
mic a membrane-like environment (Rapoport, 1985; Sitaram
and Nagaraj, 1993). When dissolved in 5% SDS, PrP (113–
127) presented a high content of a-helical structure, as
shown by two negative absorptions of nearly the same in-
tensity at 207 and 221 nm and the positive band at 192 nm
(Fig. 7). The presence of the b-sheet structure could be
deduced from the broadening of absorption peaks at 207 and
221 nm. PrP (113–120) also takes more of a helical structure
in 5% SDS (Fig. 7). To extend the observation of the stability
of the b-sheet structure of PrP (113–127), up to 5% SDS was
added to the solution of PrP (113–127) in 200 mM phosphate
buffer, pH 5 or 7. In such a high ionic condition, the existing
b-sheet gets converted into an a-helical structure. It should
be mentioned that the longer PrP (106–126) was reported to
show no changes in the b-sheet content when treated with
5% SDS (Gioia et al., 1994). This is because the b-sheet in
the amyloid assemblage is quite stable to be disassembled by
SDS micelles. The dissolution of PrP (113–127) assemblage
in SDS may be due to lack of KTNMKHM sequence. The
hydrophobic part AGAAAAGAVVGGLGG offers a suitable
module for interacting with membranes. This pattern has
been very frequently observed in peptide fragments involved
in membrane translocation of proteins (Rapoport, 1985;
Wickner and Lodish, 1985), and a transition toward the
b-sheet conformation was observed in signal peptides in
a highly hydrophobic environment (Laxma Reddy and
Nagaraj, 1989). This environment-dependent structural
transition leads us to infer that the PrPc to PrPsc transition
occurring in the post-translational process may be driven by
the nature of the environment around the PrPc and the for-
mation of intermolecular hydrogen bonding.
To study the effect of pH on the secondary structure of PrP
(113–127), CD spectra were taken at pH 2, 5, 7, and 10.6.
The CD spectra are shown in Fig. 8. It is observed that PrP
(113–127) takes sheet conformation in all the conditions (pH
2, 5, 7, and 10.6), suggesting the mode of aggregation in
aqueous conditions. It should be noted that there is slight
variation in the characteristic of sheet conformation in
different pHs. The PrP (106–126) was reported to show sheet
conformation at pH 5 and less ordered conformation at pH 7
(Gioia et al., 1994). These results indicate the importance of
the hydrophobic segment 113–127 in deciding the PrP (106–
126) conformation at pH 5. Also, the strength of sheet
conformation in different pHs does not change on increas-
ing the strength of the buffer solution, implying that the
secondary structure of PrP (113–127) is independent of the
ionic strength of the medium, which indicates the negligible
role of electrostatic interaction in aggregation.
In aqueous solution at physiological pH, PrP (113–127)
readily aggregates, a process that occurs during amyloid
formation in prion diseases. PrP (113–127) on dissolution
in 50% acetonitrile at pH 4 (adjusted with formic acid
unbuffered) forms gel, whereas PrP (113–120) does not.
FIGURE 7 CD spectrum of PrP (113–127) (——) and PrP (113–120)
(), in 5% sodium dodecyl sulfate.
FIGURE 8 CD spectrum of PrP (113–127) in pH 2 (), pH 5 (— —),
pH 7 (), and pH 10.6 (——).
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The absence of gel formation in PrP (113–120) in this
condition indicates the importance of the tail portion in
driving the molecule to form the gel. Gasset et al. (1992)
have suggested the tail region VVGGLGG has no role in
forming the sheet structure of PrP (113–127). However,
the gel formation exhibited by the PrP (113–127) leads us
to infer that critical length may be required to form
amyloid ﬁbrils, in addition to its hydrophobic character.
The morphological property of PrP (113–127) in the gel
form was analyzed using electron micrographs, shown in
Fig. 9 A. In general, formation of a gel requires the gelator
to separate the ﬁnely dispersed aggregate particles to make
them join together and form a continuous coherent
framework throughout the ﬂuid volume (Hermans, 1949).
Hence, the development of a three-dimensional network by
the gelator to capture small domains of isotropic ﬂuid is
critical to gel formation (Kishore et al., 1987; Jayakumar
et al., 2000). The size and shape of the building blocks for
the network may vary greatly between gels, but all must
have an immobile framework in which the ﬂuid is trapped.
From Fig. 9 A it is seen that the ﬁbrous texture exists,
which is attributed to the network supporting the ﬂuid
component in the gel. The schematic representation of the
structure of the gel state is shown in Fig. 9 B. The
approximate diameter of the ﬁbrillar bundle is around 10
nm. The ﬁbrils appear to be three-dimensional and
interlocking and to consist of ﬁbrillar bundles. However,
on diluting the gel with water, the ﬁbers of the bundles
interwine to immobilize the isotropic ﬂuid, probably
gained by surface tension (Fig. 9 C). The schematic
representation of the structure developing ﬁbrils is shown
in Fig. 9 D. Perhaps as a consequence of the weakness of
the attractive forces responsible for their stability, the
ﬁbers are seemingly ﬂexible. Also, the driving force for
the gel to form ﬁbers may be due to its overall
hydrophobicity. The developing ﬁbrils of PrP (113–127)
on water are shown in Fig. 9 C. The well-developed ﬁbrils
formed from PrP (113–127) were reported by Gasset et al.
(1992). It is found that the diameter of the developing
ﬁbrils of PrP (113–127) (9 nm) is similar to the previous
report (Gasset et al., 1992).
CONCLUSION
This work describes the conformational preferences of
the prion fragments PrP (113–127) and PrP (113–120) in
FIGURE 9 Electron micrographs of PrP (113–127). (A) In the gel form; (B) the schematic representation in the gel form; (C) after diluting with water; and
(D) the schematic representation after diluting with water.
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different microenvironments attained by TFE/water mix-
tures, 5% SDS and different pH conditions. The TFE titration
study of PrP (113–127) shows that hydrophobic environ-
ment around the peptide backbone drives the peptide to take
the helical conformation. This is further evidenced by the
existence of helical conformation in 5% SDS, where the
environment around the peptide backbone is hydrophobic.
On the other hand, hydrophilic environment around the
peptide backbone drives the secondary structure to take the
sheet conformation as observed by the existence of sheet
conformation on the glass surface. Further, the conformation
of PrP (113–127) transitions seems to be a two-stage process
involving the helical and sheet structure, where the mo-
lecular crowding effect and hydrophobic interaction play
a crucial role. By considering both the above conclusion and
from the enumeration from the TFE titration, the mechanism
of aggregation as shown in Fig. 10 is proposed.
Thus, the major driving forces for the PrP (113–127) to
self-assemble are the greater hydrophobicity and intermo-
lecular hydrogen bonding. These support the contention
that the ability to form amyloid ﬁbrils is a generic property
of polypeptide chains and that absence of ﬁbril in normally
functioning organisms is a consequence of the control and
regulation mechanisms that have evolved to ensure that
proteins ﬁnd and maintain their correctly folded functional
structures (Guijarro et al., 1998; Chiti et al., 1999; Grob et al.,
1999). The emerging universality in these properties of
amyloid ﬁbrils may be of help in the quest for therapeutic
substances that block this misfolding event in the context of
human diseases.
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